259 related articles for article (PubMed ID: 24768944)
1. Role of epigenetic mechanisms in epithelial-to-mesenchymal transition of breast cancer cells.
Nickel A; Stadler SC
Transl Res; 2015 Jan; 165(1):126-42. PubMed ID: 24768944
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic control of epithelial-to-mesenchymal transition and cancer metastasis.
Wang Y; Shang Y
Exp Cell Res; 2013 Jan; 319(2):160-9. PubMed ID: 22935683
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic regulation of epithelial-mesenchymal transition.
Sun L; Fang J
Cell Mol Life Sci; 2016 Dec; 73(23):4493-4515. PubMed ID: 27392607
[TBL] [Abstract][Full Text] [Related]
4. A comprehensive DNA methylation profile of epithelial-to-mesenchymal transition.
Carmona FJ; Davalos V; Vidal E; Gomez A; Heyn H; Hashimoto Y; Vizoso M; Martinez-Cardus A; Sayols S; Ferreira HJ; Sánchez-Mut JV; Morán S; Margelí M; Castella E; Berdasco M; Stefansson OA; Eyfjord JE; Gonzalez-Suarez E; Dopazo J; Orozco M; Gut IG; Esteller M
Cancer Res; 2014 Oct; 74(19):5608-19. PubMed ID: 25106427
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic modulation of the miR-200 family is associated with transition to a breast cancer stem-cell-like state.
Lim YY; Wright JA; Attema JL; Gregory PA; Bert AG; Smith E; Thomas D; Lopez AF; Drew PA; Khew-Goodall Y; Goodall GJ
J Cell Sci; 2013 May; 126(Pt 10):2256-66. PubMed ID: 23525011
[TBL] [Abstract][Full Text] [Related]
6. A prospective epigenetic paradigm between cellular senescence and epithelial-mesenchymal transition in organismal development and aging.
Kishi S; Bayliss PE; Hanai J
Transl Res; 2015 Jan; 165(1):241-9. PubMed ID: 24924348
[TBL] [Abstract][Full Text] [Related]
7. Genetic and epigenetic aspects of breast cancer progression and therapy.
Byler S; Goldgar S; Heerboth S; Leary M; Housman G; Moulton K; Sarkar S
Anticancer Res; 2014 Mar; 34(3):1071-7. PubMed ID: 24596345
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic regulation of epithelial to mesenchymal transition.
Huangyang P; Shang Y
Curr Cancer Drug Targets; 2013 Nov; 13(9):973-85. PubMed ID: 24168185
[TBL] [Abstract][Full Text] [Related]
9. Modulation of intracellular iron metabolism by iron chelation affects chromatin remodeling proteins and corresponding epigenetic modifications in breast cancer cells and increases their sensitivity to chemotherapeutic agents.
Pogribny IP; Tryndyak VP; Pogribna M; Shpyleva S; Surratt G; Gamboa da Costa G; Beland FA
Int J Oncol; 2013 May; 42(5):1822-32. PubMed ID: 23483119
[TBL] [Abstract][Full Text] [Related]
10. Gene methylation in gastric cancer.
Qu Y; Dang S; Hou P
Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
[TBL] [Abstract][Full Text] [Related]
11. The landscape of histone acetylation involved in epithelial-mesenchymal transition in lung cancer.
Zhang L; Liu Z; Ma W; Wang B
J Cancer Res Ther; 2013 Sep; 9 Suppl 2():S86-91. PubMed ID: 24135248
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic reprogramming and post-transcriptional regulation during the epithelial-mesenchymal transition.
Wu CY; Tsai YP; Wu MZ; Teng SC; Wu KJ
Trends Genet; 2012 Sep; 28(9):454-63. PubMed ID: 22717049
[TBL] [Abstract][Full Text] [Related]
13. Global and gene specific DNA methylation in breast cancer cells was not affected during epithelial-to-mesenchymal transition in vitro.
Smolkova B; Miklikova S; Kajabova VH; Babelova A; Yamani NE; Zduriencikova M; Fridrichova I; Zmetakova I; Krivulcik T; Kalinkova L; Matuskova M; Kucerova L; Dusinska M
Neoplasma; 2016; 63(6):901-910. PubMed ID: 27565328
[TBL] [Abstract][Full Text] [Related]
14. Targeted therapy of epigenomic regulatory mechanisms controlling the epithelial to mesenchymal transition during tumor progression.
Mishra VK; Johnsen SA
Cell Tissue Res; 2014 Jun; 356(3):617-30. PubMed ID: 24833164
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic regulatory mechanisms during preimplantation development.
Corry GN; Tanasijevic B; Barry ER; Krueger W; Rasmussen TP
Birth Defects Res C Embryo Today; 2009 Dec; 87(4):297-313. PubMed ID: 19960551
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic mechanisms of breast cancer: an update of the current knowledge.
Karsli-Ceppioglu S; Dagdemir A; Judes G; Ngollo M; Penault-Llorca F; Pajon A; Bignon YJ; Bernard-Gallon D
Epigenomics; 2014; 6(6):651-64. PubMed ID: 25531258
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic reprogramming in breast cancer: from new targets to new therapies.
Katz TA; Huang Y; Davidson NE; Jankowitz RC
Ann Med; 2014 Sep; 46(6):397-408. PubMed ID: 25058177
[TBL] [Abstract][Full Text] [Related]
18. Aberrant de novo methylation of the p16INK4A CpG island is initiated post gene silencing in association with chromatin remodelling and mimics nucleosome positioning.
Hinshelwood RA; Melki JR; Huschtscha LI; Paul C; Song JZ; Stirzaker C; Reddel RR; Clark SJ
Hum Mol Genet; 2009 Aug; 18(16):3098-109. PubMed ID: 19477956
[TBL] [Abstract][Full Text] [Related]
19. Interplay between different epigenetic modifications and mechanisms.
Murr R
Adv Genet; 2010; 70():101-41. PubMed ID: 20920747
[TBL] [Abstract][Full Text] [Related]
20. Epigenetics and arterial hypertension: the challenge of emerging evidence.
Friso S; Carvajal CA; Fardella CE; Olivieri O
Transl Res; 2015 Jan; 165(1):154-65. PubMed ID: 25035152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
